113 related articles for article (PubMed ID: 1873909)
1. A simple micromethod for rapid assessment of the distribution of apolipoprotein C isoforms in very-low-density lipoprotein.
Harake B; Caines PS; Thibert RJ; Cheung RM
Clin Biochem; 1991 Jun; 24(3):255-60. PubMed ID: 1873909
[TBL] [Abstract][Full Text] [Related]
2. Rapid assessment of the distribution of apolipoproteins C-II and C-III subspecies in triglyceride-rich lipoproteins by isoelectric focusing.
Bugugnani MJ; Koffigan M; Kora I; Ouvry D; Clavey V; Fruchart JC
Clin Chem; 1984 Mar; 30(3):349-51. PubMed ID: 6697477
[TBL] [Abstract][Full Text] [Related]
3. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout.
Macfarlane DG; Midwinter CA; Dieppe PA; Bolton CH; Hartog M
Ann Rheum Dis; 1985 Jun; 44(6):390-4. PubMed ID: 4015201
[TBL] [Abstract][Full Text] [Related]
5. [Composition and distribution of lipid and apolipoprotein in plasma lipoproteins of endogenous hypertriglyceridemia].
Zhang L; Liu B
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun; 23(2):117-21. PubMed ID: 1452137
[TBL] [Abstract][Full Text] [Related]
6. Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.
Hiukka A; Fruchart-Najib J; Leinonen E; Hilden H; Fruchart JC; Taskinen MR
Diabetologia; 2005 Jun; 48(6):1207-15. PubMed ID: 15864534
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of apolipoproteins CII, CIII1, CIII2 and VLDL-B in human subjects consuming high carbohydrate diets.
Huff MW; Nestel PJ
Metabolism; 1982 May; 31(5):493-8. PubMed ID: 6952065
[TBL] [Abstract][Full Text] [Related]
8. Identification and metabolic characteristics of an apolipoprotein C-II variant isolated from a hypertriglyceridemic subject.
Huff MW; Evans AJ; Wolfe BM; Connelly PW; Maguire GF; Strong WL
J Lipid Res; 1990 Mar; 31(3):385-96. PubMed ID: 2341805
[TBL] [Abstract][Full Text] [Related]
9. Purification of anti-apolipoprotein CIII antibodies by exploiting their affinity for apolipoprotein CIII linked to polyacrylamide gel after isoelectric focusing.
Alsayed N; Drüeke TB; Lacour B
Clin Chem; 1988 Jan; 34(1):49-52. PubMed ID: 3338184
[TBL] [Abstract][Full Text] [Related]
10. Immunoturbidimetric techniques for quantifying apolipoproteins CII and CIII.
Rifai N; Silverman LM
Clin Chem; 1986 Oct; 32(10):1969-72. PubMed ID: 3093121
[TBL] [Abstract][Full Text] [Related]
11. Changing relative proportions of apolipoproteins CII and CIII of very low density lipoproteins in hypertriglyceridaemia.
Carlson LA; Ballantyne D
Atherosclerosis; 1976; 23(3):563-8. PubMed ID: 178329
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
13. Decreased VLDL apoprotein CII/apoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment.
Wakabayashi Y; Okubo M; Shimada H; Sato N; Koide A; Marumo F; Nakamura H
Metabolism; 1987 Sep; 36(9):815-20. PubMed ID: 3626863
[TBL] [Abstract][Full Text] [Related]
14. [Separation and purification of human apolipoproteins A-I and C-III by chromatofocusing].
Cheng B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Aug; 15(4):280-5. PubMed ID: 8168208
[TBL] [Abstract][Full Text] [Related]
15. Effect of human high density lipoproteins, anti-apolipoproteins CII and CIII, and hydrolysis of very low density lipoprotein (VLDL) cholesterol ester on VLDL catabolism in vitro.
Liu BW; Hynd BA; Kashyap ML
Biochem Biophys Res Commun; 1984 Jun; 121(3):946-52. PubMed ID: 6588972
[TBL] [Abstract][Full Text] [Related]
16. Apolipoproteins C in very low density lipoproteins (VLDL) in idiopathic hyperlipoproteinaemia.
Kłosiewicz-Latoszek L; Naruszewicz M; Szostak WB; Nowicka G
Acta Physiol Pol; 1982; 33(1-2):57-63. PubMed ID: 7158381
[TBL] [Abstract][Full Text] [Related]
17. Distribution of CII and CIII peptides in lipoprotein classes: methods and clinical significance.
Graziani MS; Zanolla L; Righetti G; Marchetti C; Zanotto G; Lupo A
Clin Chem; 1994 Feb; 40(2):240-4. PubMed ID: 8313600
[TBL] [Abstract][Full Text] [Related]
18. Isolation and quantification of apolipoproteins C-I, C-II, and C-III0-2 in very-low-density lipoproteins by "high-performance" anion-exchange chromatography.
Weisweiler P; Friedl C; Schwandt P
Clin Chem; 1986 Jun; 32(6):992-4. PubMed ID: 3708824
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
[TBL] [Abstract][Full Text] [Related]
20. Changes in lipoproteins induced by the remnant kidney tissue or binephrectomy in chronic uremic patients treated by hemodialysis.
Robert D; Jeanmonod R; Favre H; Fruchart JC; Sturzenegger E; Riesen W
Metabolism; 1989 Jun; 38(6):514-21. PubMed ID: 2498613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
